Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 745.22M P/E 1,188.00 EPS this Y -420.00% Ern Qtrly Grth -
Income -17.68M Forward P/E 79.20 EPS next Y 40.60% 50D Avg Chg -18.00%
Sales 136.74M PEG -1.70 EPS past 5Y - 200D Avg Chg -25.00%
Dividend N/A Price/Book 3.93 EPS next 5Y 15.00% 52W High Chg -44.00%
Recommedations 2.00 Quick Ratio 0.28 Shares Outstanding 63.48M 52W Low Chg 5.00%
Insider Own 1.07% ROA -2.27% Shares Float 55.37M Beta 1.56
Inst Own 100.19% ROE -9.67% Shares Shorted/Prior 11.06M/10.11M Price 11.88
Gross Margin 7.47% Profit Margin -12.93% Avg. Volume 579,688 Target Price 12.50
Oper. Margin -11.83% Earnings Date Jun 19 Volume 520,273 Change -0.25%
About Avid Bioservices, Inc.

Avid Bioservices, Inc., a contract development and manufacturing organization, provides process development and current good manufacturing practices (CGMP) clinical and commercial manufacturing services of biologics for the biotechnology and biopharmaceutical industries. The company offers various services, including clinical and commercial drug substance manufacturing, bulk packaging, release and stability testing, and regulatory submission and support. It also provides various process development services, such as upstream and downstream development and optimization, analytical methods development, cell line development, testing, and characterization. The company was formerly known as Peregrine Pharmaceuticals, Inc. and changed its name to Avid Bioservices, Inc. in January 2018. Avid Bioservices, Inc. was incorporated in 1981 and is headquartered in Tustin, California.

Avid Bioservices, Inc. News
05/07/24 Avid Bioservices to Participate at Upcoming Investor Conferences
05/03/24 How Novo-Catalent Deal Affects Halozyme (HALO)?
04/30/24 Q3 2024 Avid Bioservices Inc Earnings Call
04/30/24 Avid Bioservices Inc (CDMO) Q3 2024 Earnings Call Transcript Highlights: Navigating Challenges ...
04/24/24 Avid Bioservices Reports Financial Results for Third Quarter Ended January 31, 2024
03/20/24 Avid Bioservices Announces Receipt of Deficiency Notice from Nasdaq Regarding Late Form 10-Q
03/10/24 Avid Bioservices Inc (CDMO) Releases Preliminary Q3 Financial Results
03/06/24 Avid Bioservices Announces Pricing of Private Placement of Convertible Notes
03/06/24 Avid Bioservices Announces Proposed Private Placement of Convertible Notes
03/06/24 Avid Bioservices Announces Certain Preliminary Financial Results for Third Quarter Ended January 31, 2024
01/30/24 Avid Bioservices (CDMO) Declined in 2023
01/12/24 Insider Stock Buying Reaches US$527.5k On Avid Bioservices
12/19/23 Director Richard Hancock's Strategic 23,000 Share Purchase in Avid Bioservices Inc
12/08/23 Avid Bioservices, Inc. (NASDAQ:CDMO) Q2 2024 Earnings Call Transcript
12/07/23 Avid Bioservices Inc (CDMO) Adjusts Fiscal 2024 Revenue Guidance Amidst Second Quarter Challenges
12/07/23 Avid Bioservices (CDMO) Reports Q2 Loss, Lags Revenue Estimates
12/07/23 Avid Bioservices Reports Financial Results for Second Quarter Ended October 31, 2023
12/01/23 Uber Technologies, Jabil and Builders FirstSource Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600
11/30/23 Avid Bioservices to Report Financial Results for Second Quarter of Fiscal Year 2024 After Market Close on December 7, 2023
11/28/23 Down -22.27% in 4 Weeks, Here's Why Avid Bioservices (CDMO) Looks Ripe for a Turnaround
CDMO Chatroom

User Image LetsG0Brandon Posted - 1 hour ago

$CDMO Still in from 8.17 likely will sell 1/2 around 9 if tested. Since it was tested in the AH Fri I wouldn't be surprised to see that today.

User Image John2029 Posted - 2 hours ago

$CDMO 🤞😃

User Image CDMO Posted - 2 hours ago

@kingofmaryland21 they changed the biosecure act thats in the works in the government to give companies time until 2033 to move away from chinese CDMOs. Might bring business to $CDMO . Its on fierce pharma, you should find it. Extract: "Right after an industry survey suggested that switching away from Chinese CDMOs could take biopharma companies up to eight years, lawmakers have adjusted the BIOSECURE Act. The new draft lays out a 2032 deadline for the separation mandate. The House version of the BIOSECURE Act has been amended to grandfather existing contracts that drug developers may have with five China-related biopharma service providers, including both WuXi Apptec and its sister contract manufacturer WuXi Biologics. Those relationships, including negotiated option years, are now exempt from national security scrutiny under the proposed legislation until Jan. 1, 2032, according to the revised bill seen by Fierce Pharma."

User Image CDMO Posted - 6 hours ago

$CDMO might help cdmo.https://www.fiercepharma.com/pharma/houses-updated-biosecurity-bill-sets-decoupling-deadline-chinese-cdmo-end-2031

User Image ForUS2Retire Posted - 1 day ago

Will Friday Nite’s Bullish AH Trading Continue In PreMarket Tomorrow? And, Could It Relate To Prior Post Regarding Takeover/Buyout Rumor? Glta $CDMO Bulls, Watchers, & StockHOLDERS!

User Image kingofmaryland21 Posted - 2 days ago

$CDMO I called it 40% ago … you’re welcome !

User Image BozoJoeClownShow Posted - 2 days ago

$CDMO Made it after hours! Can’t wait for Monday.

User Image ForUS2Retire Posted - 4 days ago

Discussion Continues About Rumor Of Possible Takeover/Buyout @$15 Glta $CDMO Bulls, Watchers, & StockHOLDERS! Several Posts Starting w/This Link: https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174376032

User Image LetsG0Brandon Posted - 5 days ago

$CDMO In at 8.17 but this is up 12 days in a row and RSI is hot. It "may" test the $9 area but I expect a healthy pull back before too long. TBS

User Image John2029 Posted - 1 week ago

$CDMO let’s do this!

User Image LetsG0Brandon Posted - 1 week ago

$CDMO NP currently but considering starting one by days end.

User Image ForUS2Retire Posted - 1 week ago

$CDMO Intetesting: 2,000Shares @$8.61 In PreMarket! Glta Bulls, Watchers, & StockHOLDERS!

User Image insiderbuyingselling Posted - 1 week ago

$CDMO new insider selling: 1643 shares. http://insiderbuyingselling.com/?t=CDMO

User Image insiderbuyingselling Posted - 1 week ago

$CDMO new insider selling: 1233 shares. http://insiderbuyingselling.com/?t=CDMO

User Image John2029 Posted - 1 week ago

$CDMO can we do $9 tomorrow?

User Image BozoJoeClownShow Posted - 1 week ago

$CDMO love it! But would like to see some news responsible for the move. 🤔

User Image ForUS2Retire Posted - 1 week ago

$CDMO Bulls Need To JumpOver $7.85 LID. Glta Bulls, Watchers, & StockHOLDERS!

User Image ForUS2Retire Posted - 1 week ago

Could Cohen/P72 Be Takeover Activist(Or Buyer)? IF So, $CDMO Is Easy Short Term Double ;-) Glta Bulls, Watchers, & StockHOLDERS!

User Image ForUS2Retire Posted - 1 week ago

Rumor: $CDMO $15 Takeover Coming. IF True, That’s A Quick Double, Though Less Than I Wanted. Glta Bulls, Watchers, & StockHOLDERS! Link: https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174342841

User Image ForUS2Retire Posted - 1 week ago

I’m Surprised There Aren’t Any Bullish Candle Analysis Posts For Avid $CDMO. Glta Bulls, Watchers, & StickHOLDERS!

User Image ForUS2Retire Posted - 04/29/24

Can $CDMO Touch $8, Then Have Positive CC? Glta Bulls, Watchers, & StockHOLDERS!

User Image matmasr Posted - 04/29/24

$CDMO Only issue is it pierced upper Bollinger band

User Image matmasr Posted - 04/29/24

$CDMO a recent Moon Shot Alert is showing strength again. Looking for an entry here

User Image ForUS2Retire Posted - 04/29/24

$CDMO CC At 4:30pmET Link: https://edge.media-server.com/mmc/p/k98krq4b/ Glta Bulls Watchers, & StockHOLDERS!

User Image BozoJoeClownShow Posted - 04/25/24

$CDMO how about, oh I don’t know, get the jobs done so you don’t have a backlog twice your annual revenue.

User Image kingofmaryland21 Posted - 04/25/24

$CDMO The BD and operations teams need to deliver, execute, and recognize all the backlog contracts and projects they have signed on. The fact that their backlog is at an all-time high shows that the high interest rates, and easy cheap money drying up haven't affected their business as much as it has hurt Lonza and Catalent. With interest rates eventually going lower, it will bring more business to Avid. What I'm trying to say here is that the worst is behind them, and they have performed much better than other big-name CDMOs during these challenging months and years.

User Image ForUS2Retire Posted - 04/24/24

"Immaterial" Also Implies, The PPS Crash From $8's... $20's & Also Possibly The $30's!... Were All Over Reactions And Market Manipulation! I'm Holding To See Rebound From This Fiasco, Which, As Far As I'm Concerned, Could Have Been All Planned!... In The Future, Many May Look Back And Realize The Buyer Of $CDMO Really Simply Manipulated Things That The SEC Simply Doesn't Oversee! Glta Bulls, Watchers, & StockHOLDERS!

User Image ForUS2Retire Posted - 04/24/24

Btw, Today Should Resolve All NASDAQ $CDMO Noncompliance Issues! Glta Bulls, Watchers, & StockHOLDERS!

User Image DonCorleone77 Posted - 04/24/24

$CDMO Avid Bioservices still sees FY24 revenue $137M-$147M, consensus $138.66M

User Image DonCorleone77 Posted - 04/24/24

$CDMO Avid Bioservices reports Q3 EPS (9c), consensus (5c) Reports Q3 revenue $33.82M, consensus $33.45M. CEO Nick Green stated, "During Q3 we had stronger revenues and an increase in bookings as compared to Q2 2024. We ended the quarter with a record high backlog of $206M. We have achieved record backlogs for four of the last five quarters, demonstrating the continued momentum in the business. The quarter is consistent with the revenue and backlog ramp that we projected for the second half of the year and we expect the momentum to continue as we transition into our fiscal year 2025 with new business wins starting to flow through our financials. During Q3, we also observed an incremental improvement in our pipeline mix. On the operations front, we recently hosted a grand opening of our cell and gene therapy CGT facility...Avid estimates that its combined facilities now have a total revenue generating capacity of up to approximately $400M annually. Today, Avid is a larger, more capable, world-class organization, poised to benefit from the tailwinds in multiple CDMO markets...As we continue to fill capacity and attract customers to our new capabilities, we believe we are well on our way to achieving the growth trajectory and sustainable profitability that will establish Avid as the supplier of choice for the industry."

Analyst Ratings
RBC Capital Outperform Apr 30, 24
Stephens & Co. Overweight Mar 11, 24
RBC Capital Outperform Mar 7, 24
RBC Capital Outperform Dec 8, 23
Craig-Hallum Buy Dec 8, 23
Keybanc Overweight Dec 8, 23
William Blair Market Perform Sep 28, 23
RBC Capital Outperform Sep 8, 23
RBC Capital Outperform Jun 22, 23
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Kwietniak Matthew R. Chief Commercial Off.. Chief Commercial Officer Jan 11 Sell 6.77 274 1,855 19,829 01/12/24
Ziebell Mark R V. P., General Couns.. V. P., General Counsel Jan 09 Sell 6.17 1,346 8,305 63,269 01/11/24
Richieri Richard A. Chief Operations Off.. Chief Operations Officer Jan 09 Sell 6.17 1,171 7,225 5,208 01/11/24
Kwietniak Matthew R. Chief Commercial Off.. Chief Commercial Officer Jan 09 Sell 6.17 1,060 6,540 19,434 01/11/24
Hart Daniel R Chief Financial Offi.. Chief Financial Officer Jan 09 Sell 6.17 2,408 14,857 79,305 01/11/24
Hancock Richard B Director Director Dec 13 Buy 5.2067 38,803 202,036 117,563 01/10/24
Hancock Richard B Director Director Dec 14 Buy 5.86 23,000 134,780 78,760 12/18/23
Kwietniak Matthew R. Chief Commercial Off.. Chief Commercial Officer Oct 11 Sell 9.19 255 2,343 17,961 10/13/23
Ziebell Mark R V. P., General Couns.. V. P., General Counsel Oct 09 Sell 9.2 1,141 10,497 60,515 10/11/23
Richieri Richard A. Chief Operations Off.. Chief Operations Officer Oct 09 Sell 9.2 1,006 9,255 4,177 10/11/23
Kwietniak Matthew R. Chief Commercial Off.. Chief Commercial Officer Oct 09 Sell 9.2 970 8,924 17,546 10/11/23
Hart Daniel R Chief Financial Offi.. Chief Financial Officer Oct 09 Sell 9.2 2,040 18,768 75,081 10/11/23
Carleone Joseph Director Director Sep 21 Buy 9.5348 20,000 190,696 93,956 09/22/23
Green Nicholas Stewart President & CEO President & CEO Jul 30 Sell 12.99 19,519 253,552 145,844 08/01/23
Richieri Richard A. Chief Operations Off.. Chief Operations Officer Jul 13 Sell 13.40 2,734 36,636 4,035 07/14/23
Kwietniak Matthew R. Chief Commercial Off.. Chief Commercial Officer Jul 11 Sell 13.61 252 3,430 15,984 07/13/23
Ziebell Mark R V. P., General Couns.. V. P., General Counsel Jul 10 Sell 13.86 5,015 69,508 58,449 07/12/23
Richieri Richard A. Chief Operations Off.. Chief Operations Officer Jul 10 Sell 13.86 1,542 21,372 6,769 07/12/23
Hart Daniel R Chief Financial Offi.. Chief Financial Officer Jul 10 Sell 13.86 3,763 52,155 71,380 07/12/23
Ziebell Mark R V. P., General Couns.. V. P., General Counsel Jul 09 Sell 13.77 687 9,460 49,173 07/11/23
Richieri Richard A. Chief Operations Off.. Chief Operations Officer Jul 09 Sell 13.77 564 7,766 6,602 07/11/23
Kwietniak Matthew R. Chief Commercial Off.. Chief Commercial Officer Jul 09 Sell 13.77 477 6,568 15,567 07/11/23
Hart Daniel R Chief Financial Offi.. Chief Financial Officer Jul 09 Sell 13.77 1,269 17,474 64,420 07/11/23
Green Nicholas Stewart President & CEO President & CEO Jul 09 Sell 13.77 7,530 103,688 127,863 07/11/23
Ziebell Mark R V. P., General Couns.. V. P., General Counsel Jun 28 Sell 13.1 3,657 47,907 46,975 06/30/23
Richieri Richard A. Chief Operations Off.. Chief Operations Officer Jun 28 Sell 12.7 2,758 35,027 17,163 06/30/23
Kwietniak Matthew R. Chief Commerical Off.. Chief Commerical Officer Jun 28 Sell 12.7 3,947 50,127 14,067 06/30/23
Hart Daniel R Chief Financial Offi.. Chief Financial Officer Jun 28 Sell 12.7 6,884 87,427 61,141 06/30/23
Green Nicholas Stewart President & CEO President & CEO Jun 28 Sell 12.7 40,856 518,871 120,067 06/30/23
Hancock Richard B Director Director Jun 06 Sell 16.18 5,000 80,900 39,134 06/08/23
Hancock Richard B Director Director Jun 06 Option 4.53 12 54 39,146 06/08/23
Ziebell Mark R V. P., General Couns.. V. P., General Counsel May 01 Sell 17.91 25,000 447,750 40,119 05/02/23
Ziebell Mark R V. P., General Couns.. V. P., General Counsel May 01 Option 9.87 25,000 246,750 65,119 05/02/23
Hancock Richard B Director Director May 01 Sell 17.92 5,000 89,600 39,134 05/02/23
Hancock Richard B Director Director May 01 Option 4.67 5,000 23,350 44,134 05/02/23
Green Nicholas Stewart President & CEO President & CEO Apr 13 Sell 20.9165 7,000 146,416 83,531 04/14/23
SARGEN GREGORY Director Director Apr 11 Sell 20.2423 7,011 141,919 04/12/23
Ziebell Mark R V. P., General Couns.. V. P., General Counsel Apr 09 Sell 19.8 736 14,573 40,119 04/11/23
Hart Daniel R Chief Financial Offi.. Chief Financial Officer Apr 09 Sell 19.8 1,280 25,344 48,549 04/11/23
Green Nicholas Stewart President & CEO President & CEO Apr 09 Sell 19.8 7,598 150,440 90,531 04/11/23
Hart Daniel R Chief Financial Offi.. Chief Financial Officer Apr 05 Sell 19 1,250 23,750 46,207 04/07/23
Hart Daniel R Chief Financial Offi.. Chief Financial Officer Apr 05 Option 5.66 500 2,830 46,707 04/07/23
Hart Daniel R Chief Financial Offi.. Chief Financial Officer Mar 14 Sell 19 5,000 95,000 46,957 03/16/23
Hart Daniel R Chief Financial Offi.. Chief Financial Officer Mar 14 Option 5.66 2,000 11,320 48,957 03/16/23
Hancock Richard B Director Director Mar 01 Sell 16.59 5,000 82,950 39,134 03/03/23
Hancock Richard B Director Director Mar 01 Option 4.67 5,000 23,350 44,134 03/03/23
Hancock Richard B Director Director Feb 01 Sell 16.02 5,000 80,100 39,134 02/03/23
Hancock Richard B Director Director Feb 01 Option 4.67 5,000 23,350 44,134 02/03/23
Alegria Esther M. Director Director Jan 13 Sell 16.3233 5,321 86,856 01/17/23
Hancock Richard B Director Director Jan 12 Sell 16 5,000 80,000 39,134 01/13/23